Press Release





2021 March
  • 3D Biotek will move to 33 Technology Drive, Warren, NJ 07059 on April 1st, 2021.
  • The fully automatic system, 3D Cell Expansion System, will be launched to the market on Q3-2024.
2019 May
  • 3D Biotek is selected to join NJEDA's New Jersey Pavilion to BIO International Convention 2019. Press Release
  • 3D Biotek has received the ISO-13485-2016 (for medical device) certificate.
2017 June
  • GMP facility - 3D Biotek has established its facility according to GMP Standard.
  • CE-Mark and ISO-13485 (for medical device) applications for certification were submitted and review is underway.
  • 3D Cell Expansion System (3D-CES) has been successfully validated for large-scale stem cell expansion.
2017 May 3D Biotek is a US FDA registered company, and its new 3D Cell Expansion System (3D-CES) has been registered with US FDA as medical device.
2016 February 3D Biotek has moved to a new lab/office in the New Jersey Center of Excellence at Bridgewater. In addition to the clean room for manufacturing, a 100K class clean room has been built for cell/tissue culture. 3D Biotek's engineering & scientific team are developing the next-generation 3D Bioreactor system for stem cells proliferation and differentiation.
2015 October Mega Hill Corporation Limited, a Hong Kong based investment company, has acquired 100% of equity from 3D Biotek's members. Mega Hill will also provide additional investment for the company's R&D on new projects.
2011 December 3D Biotek, KIYATEC Team Up to Launch Synergistic 3D Cell Culture Products. Just Add Cells: Preassembled, Single-Use Disposable Scaffold + Plasticware Preloads are an Industry FirstGreenville, SC and North Brunswick, NJ – December 2, 2011. Click here for more detail
2010 December 3D Biotek Appoints James W. Fay to Senior Executive Vice President and a member of their management leadership team. In this capacity Mr. Fay will be responsible for global marketing, sales and all business development activities. Click here for more detail.
  December Official release of 3D Perfusion Bioreactor
  May NIST (National Institute of Standards and Technology) has selected 3D Biotek's 3D Insert-PCL as the reference scaffold for 3D tissue culture. Click here for more detail.
2008 November Official release of 3D Insert-PS (Polystyrene) product line
  April Official release of 3D Insert-PCL (Polycaprolactone) product line
Copyright © 2007-2024 3D Biotek LLC. - US FDA registered & ISO-13485-2016 certified company. All rights reserved. Last Update: 2024.04.14